JNJ

187.13

+0.16%↑

ABT

124.97

+1.57%↑

TMO

563.46

+0.49%↑

DHR

213.73

-0.01%↓

BSX

98.41

-0.28%↓

JNJ

187.13

+0.16%↑

ABT

124.97

+1.57%↑

TMO

563.46

+0.49%↑

DHR

213.73

-0.01%↓

BSX

98.41

-0.28%↓

JNJ

187.13

+0.16%↑

ABT

124.97

+1.57%↑

TMO

563.46

+0.49%↑

DHR

213.73

-0.01%↓

BSX

98.41

-0.28%↓

JNJ

187.13

+0.16%↑

ABT

124.97

+1.57%↑

TMO

563.46

+0.49%↑

DHR

213.73

-0.01%↓

BSX

98.41

-0.28%↓

JNJ

187.13

+0.16%↑

ABT

124.97

+1.57%↑

TMO

563.46

+0.49%↑

DHR

213.73

-0.01%↓

BSX

98.41

-0.28%↓

Search

Intuitive Surgical Inc

Abrir

SetorSaúde

535.56 -0.84

Visão Geral

Variação de preço das ações

24h

Atual

Mín

534.7

Máximo

545

Indicadores-chave

By Trading Economics

Rendimento

45M

709M

Vendas

65M

2.5B

P/E

Médio do Setor

72.438

37.003

EPS

2.4

Margem de lucro

28.31

Funcionários

15,638

EBITDA

28M

1B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+12.4% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

31B

195B

Abertura anterior

536.4

Fecho anterior

535.56

Sentimento de Notícias

By Acuity

31%

69%

76 / 373 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bearish Evidence

Intuitive Surgical Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

21 de out. de 2025, 23:55 UTC

Ações em Alta

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 de out. de 2025, 21:14 UTC

Ganhos
Grandes Movimentos do Mercado

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 de out. de 2025, 20:38 UTC

Ganhos

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 de jul. de 2025, 21:13 UTC

Ganhos

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 de abr. de 2025, 20:55 UTC

Ganhos

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

30 de out. de 2025, 12:38 UTC

Ganhos

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 de out. de 2025, 12:01 UTC

Ganhos

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 de out. de 2025, 15:42 UTC

Ganhos

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 de out. de 2025, 12:34 UTC

Ganhos

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 de out. de 2025, 11:49 UTC

Ganhos

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 de out. de 2025, 20:08 UTC

Ganhos

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 de out. de 2025, 20:08 UTC

Ganhos

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Net $704.4M >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 de out. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 de jul. de 2025, 20:14 UTC

Ganhos

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 de jul. de 2025, 20:13 UTC

Ganhos

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 de jul. de 2025, 20:13 UTC

Ganhos

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 de jul. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 2Q Net $658.4M >ISRG

22 de jul. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 de jul. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 de jul. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 de jul. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 de abr. de 2025, 20:13 UTC

Ganhos

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 de abr. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 de abr. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 de abr. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 1Q Net $698.4M >ISRG

22 de abr. de 2025, 20:05 UTC

Ganhos

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

Comparação entre Pares

Variação de preço

Intuitive Surgical Inc Previsão

Preço-alvo

By TipRanks

12.4% parte superior

Previsão para 12 meses

Média 611.68 USD  12.4%

Máximo 685 USD

Mínimo 440 USD

Com base em 20 analistas de Wall Street que oferecem metas de preço de 12 meses para Intuitive Surgical Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

20 ratings

16

Comprar

3

Manter

1

Vender

Pontuação Técnica

By Trading Central

514.59 / 539.05Suporte e Resistência

Curto Prazo

Weak Bearish Evidence

Médio Prazo

Weak Bullish Evidence

Longo Prazo

Strong Bullish Evidence

Sentimento

By Acuity

76 / 373 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat